Lifevantage Corp Receivables Turnover Ratio (LFVN), from the fourth quarter 2026 to the fourth quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Lifevantage Corp  (NASDAQ: LFVN)
 

Lifevantage Accounts Receivables Turnover Ratio from the fourth quarter 2026 to the fourth quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Lifevantage Corp's ability to collect accounts receivable sequentially worsen to 65.04, indicating more challenging environment then in the third quarter 2026, but still, it is a far cry from any concerns. Lifevantage's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 6 days, from 5 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 4 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 49 to 64.

What is Receivable Turnover Ratio?
What is Lifevantage Corp Selling?


What is Receivable Turnover Ratio?





LFVN Receivables Turnover Ratio (Jun 30 2026)
IV. Quarter
(Mar 31 2026)
III. Quarter
(Dec 31 2025)
II. Quarter
(Sep 30 2025)
I. Quarter
(Jun 30 2025)
IV. Quarter
Y / Y Receivable Change -9.23 % -25.31 % 11.7 % -18.3 % 11.7 %
Y / Y Revenue Change -23.02 % -25.35 % -28.65 % 0.2 % 12.55 %
Receivable Turnover Ratio (TTM) 65.04 67.74 68.03 76.51 73.14
LFVN's Total Ranking # 64 # 49 # 56 # 51 # 50
Accounts Receivable average collection period days 6 5 5 5 5
Seq. Receivable Change 23.55 % -26.53 % 35.84 % -26.38 % 1.67 %
Seq. Revenue Change -2.68 % -9.68 % 2.98 % -14.96 % -5.62 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 5
Overall Market # 64

Receivable Turnover Ratio Statistics
High Average Low
4.69 3.67 2.81
(Mar 31 2016)   (Dec 31 2021)




  News about Lifevantage Corp Receivables Turnover Ratios

An Illuminating Triumph LifeVantages Revolutionary GLP-1 System Unveiled

In this illustrious epoch, wherein the delicate dance of science and nature embarks upon yet another prodigious foray, there emerges from the hallowed halls of LifeVantage Corporation a herald of hope a resplendent beacon illuminating the oft-arduous path of weight management and optimal health. This esteemed establishment of biochemical innovation has recently completed a most successful human clinical trial, showcasing the potency of a novel GLP-1 System, poised to activate weight loss through the subliminal engagement of the corporeal faculties at the cellular level.The praiseworthy results of this pioneering study bespeak an advent of solutions that are as intricate as they are efficacious, promising to streamline one s empirical journey toward health and vitality. Through meticulous scientific inquiry and research, LifeVantage s GLP-1 System emerges, not merely as a remedy to the burgeoning concerns of excess weight that so burden the populace, but rather as a catalyst for a renaissance in healthful living one wherein the very essence of well-being is rejuvenated through the harmonious interplay of molecular symphony and nutritional wisdom.




Financial Statements
Lifevantage's Accounts Receivable $ 3 Millions Visit LFVN's Balance sheet
Lifevantage's Sales TTM $ 181 Millions Visit LFVN's Income Statement
Sources of LFVN's Revenues Visit LFVN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LFVN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LFVN's Growth Rates LFVN's Roa LFVN's Inventory Turnover Ratio LFVN's Dividend Comparisons
LFVN's Profitability Ratios LFVN's Roi LFVN's Asset Turnover Ratio LFVN's Dividend Growth
LFVN's Valuation Ratios LFVN's Roe LFVN's Financial Strength Ratios LFVN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Warby Parker Inc   161.02 $ 912.542  Millions$ 5.667  Millions
Assembly Biosciences Inc   94.77 $ 74.845  Millions$ 0.790  Millions
Arcus Biosciences Inc   93.60 $ 117.000  Millions$ 1.250  Millions
Earth Science Tech Inc   88.94 $ 34.647  Millions$ 0.390  Millions
Sbc Medical Group Holdings Incorporated  86.85 $ 173.713  Millions$ 2.000  Millions
Lenz Therapeutics Inc   77.11 $ 21.475  Millions$ 0.279  Millions
Lifevantage Corp  65.04 $ 180.947  Millions$ 2.782  Millions
Airsculpt Technologies Inc   64.88 $ 150.724  Millions$ 2.323  Millions
Stablecoin Development Corporation  61.16 $ 5.627  Millions$ 0.092  Millions
Arrowhead Pharmaceuticals Inc   60.05 $ 669.495  Millions$ 11.149  Millions
Fortrea Holdings Inc   56.65 $ 2,676.500  Millions$ 47.250  Millions
Humacyte Inc   52.69 $ 30.074  Millions$ 0.571  Millions
Brookdale Senior Living Inc   47.66 $ 3,050.697  Millions$ 64.009  Millions
National Vision Holdings Inc   44.61 $ 2,033.426  Millions$ 45.586  Millions
Meiragtx Holdings Plc  40.72 $ 397.501  Millions$ 9.762  Millions
Nature s Sunshine Products inc   39.24 $ 491.790  Millions$ 12.532  Millions
Bioadaptives Inc   35.76 $ 0.026  Millions$ 0.001  Millions
Electrocore Inc   34.09 $ 36.527  Millions$ 1.072  Millions
Innovative Eyewear Inc   31.49 $ 3.412  Millions$ 0.108  Millions
Mangoceuticals Inc   31.43 $ 0.315  Millions$ 0.010  Millions
Cv Sciences Inc   31.22 $ 12.066  Millions$ 0.387  Millions
Jaguar Health Inc   30.23 $ 27.815  Millions$ 0.920  Millions
Invo Fertility Inc   30.20 $ 7.531  Millions$ 0.249  Millions
Innovage Holding Corp   27.53 $ 989.707  Millions$ 35.951  Millions
Wave Life Sciences Ltd   26.88 $ 81.746  Millions$ 3.041  Millions
Metagenomi Therapeutics Inc   25.05 $ 13.561  Millions$ 0.541  Millions
Sonida Senior Living Inc   22.59 $ 525.973  Millions$ 23.283  Millions
U S Physical Therapy Inc  22.40 $ 812.203  Millions$ 36.251  Millions
Nutriband Inc   22.15 $ 1.618  Millions$ 0.073  Millions
Ginkgo Bioworks Holdings Inc   20.32 $ 111.863  Millions$ 5.506  Millions

Date modified: 2026-09-12T06:11:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.